SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-053567
Filing Date
2020-10-05
Accepted
2020-10-05 16:00:08
Documents
2
Period of Report
2020-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1555
2 POA DOCUMENT poa.txt EX-24.3_940149 3991
  Complete submission text file 0001209191-20-053567.txt   6944
Mailing Address C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Crowley John F (Reporting) CIK: 0001400973 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 201223507

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences